Transcriptional Factors in Calcium Mishandling and Atrial Fibrillation Development

Overview

Journal Pflugers Arch

Specialty Physiology

Date 2021 May 18

PMID 34003377

Authors

Wenli Dai

Sneha Kesaraju

Christopher R Weber

Affiliations

Soon will be listed here.

Abstract

Healthy cardiac conduction relies on the coordinated electrical activity of distinct populations of cardiomyocytes. Disruption of cell-cell conduction results in cardiac arrhythmias, a leading cause of morbidity and mortality worldwide. Recent genetic studies have highlighted a major heritable component and identified numerous loci associated with risk of atrial fibrillation, including transcription factor genes, particularly those important in cardiac development, microRNAs, and long noncoding RNAs. Identification of such genetic factors has prompted the search to understand the mechanisms that underlie the genetic component of AF. Recent studies have found several mechanisms by which genetic alterations can result in AF formation via disruption of calcium handling. Loss of developmental transcription factors in adult cardiomyocytes can result in disruption of SR calcium ATPase, sodium calcium exchanger, calcium channels, among other ion channels, which underlie action potential abnormalities and triggered activity that can contribute to AF. This review aims to summarize the complex network of transcription factors and their roles in calcium handling.

References

Darbar D, Roden D . Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nat Rev Cardiol. 2013; 10(6):317-29. PMC: 3664212. DOI: 10.1038/nrcardio.2013.53. View

Molina C, Voigt N . Finding Ms or Mr Right: Which miRNA to target in AF?. J Mol Cell Cardiol. 2016; 102:22-25. DOI: 10.1016/j.yjmcc.2016.11.007. View

Lubitz S, Lunetta K, Lin H, Arking D, Trompet S, Li G . Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J Am Coll Cardiol. 2014; 63(12):1200-1210. PMC: 4009240. DOI: 10.1016/j.jacc.2013.12.015. View

Steimle J, Moskowitz I . TBX5: A Key Regulator of Heart Development. Curr Top Dev Biol. 2017; 122:195-221. PMC: 5371404. DOI: 10.1016/bs.ctdb.2016.08.008. View

Landstrom A, Dobrev D, Wehrens X . Calcium Signaling and Cardiac Arrhythmias. Circ Res. 2017; 120(12):1969-1993. PMC: 5607780. DOI: 10.1161/CIRCRESAHA.117.310083. View

Gore-Panter S, Hsu J, Barnard J, Moravec C, Van Wagoner D, Chung M . PANCR, the PITX2 Adjacent Noncoding RNA, Is Expressed in Human Left Atria and Regulates PITX2c Expression. Circ Arrhythm Electrophysiol. 2016; 9(1):e003197. PMC: 4719779. DOI: 10.1161/CIRCEP.115.003197. View

Iwasaki Y, Nishida K, Kato T, Nattel S . Atrial fibrillation pathophysiology: implications for management. Circulation. 2011; 124(20):2264-74. DOI: 10.1161/CIRCULATIONAHA.111.019893. View

Li D, Fareh S, Leung T, Nattel S . Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999; 100(1):87-95. DOI: 10.1161/01.cir.100.1.87. View

Puskaric S, Schmitteckert S, Mori A, Glaser A, Schneider K, Bruneau B . Shox2 mediates Tbx5 activity by regulating Bmp4 in the pacemaker region of the developing heart. Hum Mol Genet. 2010; 19(23):4625-33. PMC: 2972695. DOI: 10.1093/hmg/ddq393. View

10.

Firouzi M, Bierhuizen M, Kok B, Teunissen B, Jansen A, Jongsma H . The human Cx40 promoter polymorphism -44G-->A differentially affects transcriptional regulation by Sp1 and GATA4. Biochim Biophys Acta. 2006; 1759(10):491-6. DOI: 10.1016/j.bbaexp.2006.09.002. View

11.

Patterson E, Po S, Scherlag B, Lazzara R . Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm. 2005; 2(6):624-31. DOI: 10.1016/j.hrthm.2005.02.012. View

12.

Burashnikov A, Antzelevitch C . Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation. 2003; 107(18):2355-60. DOI: 10.1161/01.CIR.0000065578.00869.7C. View

13.

Mahida S . Transcription factors and atrial fibrillation. Cardiovasc Res. 2013; 101(2):194-202. DOI: 10.1093/cvr/cvt261. View

14.

Yuan F, Qiu X, Li R, Qu X, Wang J, Xu Y . A novel NKX2-5 loss-of-function mutation predisposes to familial dilated cardiomyopathy and arrhythmias. Int J Mol Med. 2014; 35(2):478-86. DOI: 10.3892/ijmm.2014.2029. View

15.

Syeda F, Kirchhof P, Fabritz L . PITX2-dependent gene regulation in atrial fibrillation and rhythm control. J Physiol. 2017; 595(12):4019-4026. PMC: 5471504. DOI: 10.1113/JP273123. View

16.

Tse G . Mechanisms of cardiac arrhythmias. J Arrhythm. 2016; 32(2):75-81. PMC: 4823581. DOI: 10.1016/j.joa.2015.11.003. View

17.

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

18.

Heijman J, Voigt N, Nattel S, Dobrev D . Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res. 2014; 114(9):1483-99. DOI: 10.1161/CIRCRESAHA.114.302226. View

19.

Qi X, Yeh Y, Xiao L, Burstein B, Maguy A, Chartier D . Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res. 2008; 103(8):845-54. DOI: 10.1161/CIRCRESAHA.108.175463. View

20.

Andrade J, Khairy P, Dobrev D, Nattel S . The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014; 114(9):1453-68. DOI: 10.1161/CIRCRESAHA.114.303211. View